BioSpace News Archive

Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots of 25 mg strength and 29 lots of 100 mg strength).

A new 10-point manifesto from a leading research institute is calling for action to speed up access to innovative cancer drugs as an accompanying survey of 1,000 cancer patients finds many face barriers in receiving the latest treatments.

The Board of Directors of Sensient Technologies Corporation has declared a regular quarterly cash dividend on its common stock of $0.36 per share.

Gencove, the leading low-pass sequencing platform announced the receipt of a Phase I grant from the National Cancer Institute under the auspices of the Small Business Innovation Research program of the National Institutes of Health.

OncLive® will host its latest State of the Science Summit™ on hematologic malignancies on Wednesday, May 1, from 5-9 p.m. at the DoubleTree by Hilton Hotel Raleigh-Durham Airport in North Carolina.

Dr. Theresa Tam, Canada’s Chief Public Health Officer, will convene a panel discussion, hosted by the Public Policy Forum, on the spread of misinformation about vaccines on social media and the impact it is having on vaccine-preventable diseases in Canada.

Health Canada has seized multiple unauthorized drugs from Gigi’s Market in Ottawa, Ontario.

AMADA MIYACHI EUROPE announces the availability of several process technology options for interconnection of flexible materials used in manufacturing wearable technology devices.

Lonza today announced the global availability of the world’s first fully automated and integrated plate-based PyroTec™ PRO Robotic Solution for endotoxin testing.

Solentim, the global leader in cell line development (CLD) imaging instrumentation, and SAL Scientific, a leading provider of growth enhancing animal-free cell culture reagents, are pleased to announce a new strategic partnership. The collaboration will further optimise CLD workflow by supplying novel supplements which substantially improve cell growth. Solentim will act as the exclusive distributor for the SAL Scientific ‘Insti’ product range.